COMMUNIQUÉS West-GlobeNewswire

ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
26/02/2018
The WHO considers infertility a global public health issue affecting 186 million people, and only 1 in 4 ART treatments results in childbirth Geneva, Switzerland and Boston, MA - 26 February, 2018 - ObsEva SA (NASDAQ: [...]
Summit Therapeutics plc : Research Update
26/02/2018
Summit Therapeutics plc ('Summit', or 'the Company') SUMMIT ANNOUNCES NEW ANALYSIS SHOWING EZUTROMID SIGNIFICANTLY REDUCED MUSCLE INFLAMMATION IN PHASE 2 CLINICAL TRIAL IN DMD MRS-T2 Data Provide Evidence of Early [...]
Summit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMD
26/02/2018
MRS-T2 Data Provide Evidence of Early Impact of Ezutromid on Downstream Muscle Health Data Build on Positive Biopsy Findings that Showed Significant Decrease in Muscle Damage OXFORD, United Kingdom, Feb. 26, 2018 (GLOBE [...]
Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing
26/02/2018
RANCHO CORDOVA, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
Protalix BioTherapeutics to Hold Full-Year 2017 Financial Results and Corporate Update Conference Call on March 6, 2018
26/02/2018
CARMIEL, Israel, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Axsome Therapeutics Announces Primary Endpoint Met in Phase 1 Trial of Next Generation Product Candidate AXS-09 Containing Chirally Pure Esbupropion and Dextromethorphan
26/02/2018
Chirally pure and stable single enantiomers of bupropion achieved AXS-09 consists of esbupropion and dextromethorphan for CNS disorders Esbupropion is the chirally pure S -enantiomer of bupropion AXS-09 results in [...]
Edge Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 1, 2018
26/02/2018
BERKELEY HEIGHTS, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life- [...]
Resverlogix Announces Sixth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
26/02/2018
CALGARY, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX ) today announced that the independent Data and Safety Monitoring Board (DSMB) for the Company's Phase 3 [...]
Achillion Announces ACH-4471 Receives Positive Opinion for Orphan Drug Designation in the European Union for the Treatment of C3 Glomerulopathy
26/02/2018
NEW HAVEN, Conn., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), a biopharmaceutical company focused on advancing small molecule factor D inhibitors to modulate the complement [...]
Orion Group Financial Statement documents 2017 and Corporate Governance Statement published
26/02/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 26 FEBRUARY 2018 at 13.00 EET Orion Group Financial Statement documents 2017 and Corporate Governance Statement published Orion Group's Financial Statement documents for 2017 [...]
Orion Group Financial Statement documents 2017 and Corporate Governance Statement published
26/02/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 26 FEBRUARY 2018 at 13.00 EET Orion Group Financial Statement documents 2017 and Corporate Governance Statement published Orion Group's Financial Statement documents for 2017 [...]
Ascension Selects R1 for Physician Practice Revenue Cycle Management
26/02/2018
CHICAGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced plans for an expanded 10-year [...]
OraSure Technologies to Present at the Raymond James 39th Annual Institutional Investors Conference
26/02/2018
BETHLEHEM, Pa., Feb. 26, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]
R1 to Acquire Intermedix Corporation
26/02/2018
CHICAGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc . (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced a definitive agreement to [...]
Bavarian Nordic Announces Collaboration to Evaluate CV301 in Combination with durvalumab in Colorectal and Pancreatic Cancers
26/02/2018
Third evaluation of CV301 in combination with a checkpoint inhibitor Multicenter investigator-sponsored trial to be led by Georgetown University COPENHAGEN, Denmark, February 26, 2018 - Bavarian Nordic A/S (OMX: BAVA, [...]
William Demant Holding A/S: Notice to annual general meeting
26/02/2018
To the shareholders of William Demant Holding A/S 26 February 2018 Notice is hereby given of the Annual General Meeting of William Demant Holding A/S to be held on: Thursday, 22 March 2018 at 4:00pm CET at the Company's [...]
Acarix : Year-end Report, January - December 2017
26/02/2018
Press release Malmö, February 26, 2018 Year-end Report, January - December 2017 CADScor®System launched in key markets "In 2017, we achieved historic milestones in Acarix - most noticeably the receipt of our first [...]
INVITATION: Terveystalo Plc Full year 2017 result - Press conference and live webcast for analysts
26/02/2018
Terveystalo Plc will publish its Financial statements release 2017 on 28 February 2018 at approximately 9:00 a.m. Finnish time. The company will hold a press conference on 28 February, 2018, starting at 12:00 EET, at [...]
MediciNova to Present at the Cowen Health Care Conference in Boston
26/02/2018
LA JOLLA, Calif., Feb. 25, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Pages